Randomized Controlled Trial in Liver Transplant Recipients Treated in Steroid Sparing Regimen

• Status: Completed
• Trial end date: 2009-02-01
• Target enrollment: 0
• Participant gender: All

Summary

Liver transplant subjects will be given Mycophenolate (MMF) and Tacrolimus in order to help prevent post-transplant rejection.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Duke University
• Collaborator: Novartis Pharmaceuticals
• Treatments: Tacrolimus

Criteria

Inclusion Criteria:

• adult patients who have received liver transplant

Exclusion Criteria:

• pregnant women

• nursing women